Immunology News and Research

Latest Immunology News and Research

New method for identifying bacteria in patient specimens leads to 92% cost reduction

Researchers at UNC Health Care have found that using a new method for identifying bacteria and fungi in patient specimens led to a 92 percent cost reduction in the reagents needed to run clinical microbiology tests.

21 May 2014

New drug offers promising possibility for treating adults with periodontitis

Nearly half of all adults in the United States suffer from the gum disease periodontitis, and 8.5 percent have a severe form that can raise the risk of heart disease, diabetes, arthritis and pregnancy complications.

21 May 2014

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., has announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio™ (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD).

21 May 2014

Studies show mobile phones can cause allergic contact dermatitis in both children and adults

Studies have identified mobile phones and related devices as sources of metal sensitization and potential causes of allergic contact dermatitis (ACD).

21 May 2014

Cigarette smoking and male sex are independent risk factors for ocular sarcoidosis

Cigarette smoking and male sex are significant risk factors for developing ocular sarcoidosis, according to a new study presented at the 2014 American Thoracic Society International Conference.

21 May 2014

BioLineRx announces financial results for Q1 2014, provides operational update

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.

20 May 2014

TSRI chemists develop correct structure of highly promising anticancer compound

Chemists at The Scripps Research Institute (TSRI) have determined the correct structure of a highly promising anticancer compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials in cancer patients.

20 May 2014

Bacteria in urine could contribute to overactive bladder

Bacteria live in the bladders of healthy women, discrediting the common belief that normal urine is sterile. This finding was presented today by researchers from Loyola University Chicago at the 114th General Meeting of the American Society for Microbiology in Boston.

19 May 2014

Bacteria in urine may be associated with overactive bladder

Contrary to popular belief, urine is not sterile and the bacteria in it may be associated with overactive bladder (OAB) in some women, according to research presented today at the annual meeting of the American Society for Microbiology.

19 May 2014

Painkillers may prevent repeated urinary tract infections in women, says study

Women plagued by repeated urinary tract infections may be able to prevent the infections with help from over-the-counter painkillers, new research in mice shows.

19 May 2014

OLYSIO (simeprevir) receives EC marketing authorisation for treatment of genotype 1 and 4 CHC

Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.

16 May 2014

Chronic bystander viral impairs development of memory T cells

Studies of vaccine programs in the developing world have revealed that individuals with chronic infections such as malaria and hepatitis tend to be less likely to develop the fullest possible immunity benefits from vaccines for unrelated illnesses.

16 May 2014

Bristol-Myers Squibb reports updated survival data from Phase 1b study of advanced melanoma

Bristol-Myers Squibb Company today announced updated survival data from the advanced melanoma cohort of Phase 1b study.

16 May 2014

Scientists reveal how and why immune system's B cells respond only to true threats

The immune system's B cells protect us from disease by producing antibodies, or "smart bullets," that specifically target invaders such as pathogens and viruses while leaving harmless molecules alone.

16 May 2014

Study led by TSRI scientists likely to influence future designs for HIV vaccines, antibody-based therapies

A vaccine or other therapy directed at a single site on a surface protein of HIV could in principle neutralize nearly all strains of the virus—thanks to the diversity of targets the site presents to the human immune system.

16 May 2014

St. Jude analysis reveals how protein p53 triggers cancer cells to commit suicide

St. Jude Children's Research Hospital scientists have mapped the structural details of how p53 attaches to its regulatory protein, called BCL-xL, in the cell.

16 May 2014

Corgenix announces that Randox received CE Mark notification for TxBCardio Assay

Corgenix Medical Corporation announced in collaboration with Randox Laboratories that Randox has been granted CE Mark notification for its TxBCardio™ Assay.

From Randox Laboratories Ltd. 15 May 2014

Scripps Research Institute scientists show AIDS vaccine could work against changeable site on HIV

A vaccine or other therapy directed at a single site on a surface protein of HIV could in principle neutralize nearly all strains of the virus-thanks to the diversity of targets the site presents to the human immune system.

15 May 2014

Fetal membranes exposed to oxidative stress can trigger premature aging of placenta

A new study by researchers at the University of Texas Medical Branch at Galveston is the first to show that premature aging of the placenta due to oxidative stress is the cause of many preterm births. The study appears today in the American Journal of Pathology.

14 May 2014

Baylor receives $3.3M grant from NIAMS to advance research in autoimmune diseases

Baylor Research Institute has received a $3.3 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), one of the National Institutes of Health, to fund its Autoimmunity Center of Excellence.

14 May 2014

Immunology News and Research

Latest Immunology News and Research

New method for identifying bacteria in patient specimens leads to 92% cost reduction

New drug offers promising possibility for treating adults with periodontitis

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Studies show mobile phones can cause allergic contact dermatitis in both children and adults

Cigarette smoking and male sex are independent risk factors for ocular sarcoidosis

BioLineRx announces financial results for Q1 2014, provides operational update

TSRI chemists develop correct structure of highly promising anticancer compound

Bacteria in urine could contribute to overactive bladder

Bacteria in urine may be associated with overactive bladder

Painkillers may prevent repeated urinary tract infections in women, says study

OLYSIO (simeprevir) receives EC marketing authorisation for treatment of genotype 1 and 4 CHC

Chronic bystander viral impairs development of memory T cells

Bristol-Myers Squibb reports updated survival data from Phase 1b study of advanced melanoma

Scientists reveal how and why immune system's B cells respond only to true threats

Study led by TSRI scientists likely to influence future designs for HIV vaccines, antibody-based therapies

St. Jude analysis reveals how protein p53 triggers cancer cells to commit suicide

Corgenix announces that Randox received CE Mark notification for TxBCardio Assay

Scripps Research Institute scientists show AIDS vaccine could work against changeable site on HIV

Fetal membranes exposed to oxidative stress can trigger premature aging of placenta

Baylor receives $3.3M grant from NIAMS to advance research in autoimmune diseases

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging